MedTrace Logo

Same-Day Combination of VI Peel and Botox for Correction of Sun Damage, Fine Lines and Wrinkles

NCT05162300 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2022-04-25

No results posted yet for this study

Summary

This study is being conducted to improve standards of care in the cosmetic treatment of sun damage, fine lines, and wrinkles. VI Peels® and Botox® have been used cosmetically to improve patient concerns as monotherapies. This study seeks to confirm that the same-day combination creates no additional side-effects and furthermore that patient satisfaction is heightened as a result.

Conditions

  • Photoaging
  • Wrinkle
  • Sun Damaged Skin

Interventions

COMBINATION_PRODUCT

Same Day Intervention of VI Peel (Procedure) and Botulinum Toxin (Drug)

Same-Day combination of VI Peel applied to the full face, followed by Botox injection per label to the face.

Sponsors & Collaborators

  • Vitality Institute Medical Products

    lead INDUSTRY

Principal Investigators

  • Wendy E Roberts, MD · Principal Investigator

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-12-08
Primary Completion
2022-01-13
Completion
2022-02-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05162300 on ClinicalTrials.gov